Father Appeals to Russia for Experimental Cancer Vaccine Trial to Save 21-Year-Old Son's Life

Nov 16, 2025 10:23 am CST

A Lucknow father, Manu Srivastava, has received a response from Russian authorities after requesting that his 21-year-old son Ansh, who suffers from stage four cancer, be included in trials for Russia's promising new cancer vaccine. The experimental treatment has shown 60-80% effectiveness in reducing tumor size during preclinical trials but remains unavailable outside Russia.